Tag Archives: parkinson

Parkinson’s Disease, Inflammation and Oxidative Stress: Natural Help

??????????????????????????????????????????????????????????????????????

Most of us should be familiar with the disease known as Parkinson’s Disease, which ruins countless lives by creating a movement disorder characterized by shaking type of movements. It leads to difficulty moving at all, and in late stages the most common treatments lead to dyskinesthia which is a type of writhing uncontrolled movement. Without detailing the actual nerve pathways, part of the problem is neurodegeneration in a part of the brain called the basal ganglia, in an area known as the Substantia Nigra. When this area is overtaxed and inflamed, a process known as oxidative stress occurs, damaging neurons and created neurofibrous “tangles” known as α-synuclein aggregations.

There is a great deal of research that has been done to detail some natural ingredients that can be used to either prevent, or help treat Parkinson’s. These can sometimes reduce the amount of medication needed, and postpone the onset of dyskinesthia. In some cases successful treatment has occurred and symptoms are gone. The major “theme” of treatment with natural products is to reduce inflammation, block oxidative stress, and promote healthy metabolism in those neuronal cells.

Curcumin is an extract of turmeric, and contains 95% curcuminoids-the active ingredient. This makes it 19 times stronger than turmeric, which only contains 5%. Curcumin has been found to block inflammation, reduce oxidative stress, rescue nerve cells that have been affected, and even to reverse the accumulation of α-synuclein in the brain. I’ve attached a little over two dozen peer-reviewed studies about curcumin and Parkinson’s in the Bibliography. Curcumin is best taken before a meal, and with a tablespoon of coconut oil which boosts absorption and is good for the brain as well.

Another useful herb is Skullcap, Scuttelaria baikalensis, which contains the ingredient Baicalein. This has also been extensively studied for use in treating and reversing some of the effects of Parkinson’s, and is a very promising herb. Note that there aren’t any studies that look at what would happen if you use this AND curcumin, but you can imagine that it should work even better as they do not function through the same mechanisms.

The last strategy I’d like to mention is gut bacteria optimization. As I wrote an entire book about gut bacteria (The Symbiont Factor) I’ll try to be brief. Our gut bacteria wield a big influence on brain and immune function, helping to both tone and control immune function and regulate both the production of neurotransmitters and the sensitivity of neurotransmitter receptor sites in the brain. An imbalance of gut bacteria, which can be assessed with a uBiome.com gut bacteria census, can create functional changes that make the brain less efficient and more inflamed. This sets the stage for Parkinson’s, as neuroinflammation is a required building block of this disease.

Now, you might ask yourselves why this information is not more well known in the Parkinson’s world…it doesn’t actually even appear on the National Parkinson’s Foundation website although many less effective interventions are mentioned. This is because, simply, much of the research is done in search of new drugs to create by copying the action of useful herbs and natural processes. This is one way that companies explore for new drugs that can be patented. The real question is why we would wait for that, when the research shows these natural substances to be quite effective in lab and animal models. Of course, double-blind trials on humans will not be performed until drug candidates are created…so don’t look for the final proof of natural substances, because these trials are very expensive and are only carried out when a candidate drug ($$$) is being evaluated. In other words, follow the money!

Bibliography:

The Symbiont Factor: http://tinyurl.com/z5568ct

Baicalein inhibits α-synuclein oligomer formation and prevents progression of α-synuclein accumulation in a rotenone mouse model of Parkinson’s disease.

Hu Q, Uversky VN, Huang M, Kang H, Xu F, Liu X, Lian L, Liang Q, Jiang H, Liu A, Zhang C, Zhu S.

Biochim Biophys Acta. 2016 Jul 14. pii: S0925-4439(16)30168-5. doi: 10.1016/j.bbadis.2016.07.008. [Epub ahead of print]

PMID:27425033

Ameliorative effects of baicalein in MPTP-induced mouse model of Parkinson’s disease: A microarray study.

Gao L, Li C, Yang RY, Lian WW, Fang JS, Pang XC, Qin XM, Liu AL, Du GH.

Pharmacol Biochem Behav. 2015 Jun;133:155-63. doi: 10.1016/j.pbb.2015.04.004. Epub 2015 Apr 18.

PMID:25895692

Baicalein ameliorated the upregulation of striatal glutamatergic transmission in the mice model of Parkinson’s disease.

Xue X, Liu H, Qi L, Li X, Guo C, Gong D, Qu H.

Brain Res Bull. 2014 Apr;103:54-9. doi: 10.1016/j.brainresbull.2014.02.004. Epub 2014 Feb 24.

PMID:24576689

Baicalein protects against 6-OHDA-induced neurotoxicity through activation of Keap1/Nrf2/HO-1 and involving PKCα and PI3K/AKT signaling pathways.

Zhang Z, Cui W, Li G, Yuan S, Xu D, Hoi MP, Lin Z, Dou J, Han Y, Lee SM.

J Agric Food Chem. 2012 Aug 22;60(33):8171-82. doi: 10.1021/jf301511m. Epub 2012 Aug 9.

PMID:22838648

[Neuroprotective effect of baicalein in patients with Parkinson’s disease].

Yu X, He G, Du G.

Zhongguo Zhong Yao Za Zhi. 2012 Feb;37(4):421-5. Review. Chinese.

PMID:22667137

Assessment of the treatment effect of baicalein on a model of Parkinsonian tremor and elucidation of the mechanism.

Yu X, He GR, Sun L, Lan X, Shi LL, Xuan ZH, Du GH.

Life Sci. 2012 Jul 26;91(1-2):5-13. doi: 10.1016/j.lfs.2012.05.005. Epub 2012 May 23.

PMID:22634324

Baicalein inhibits formation of α-synuclein oligomers within living cells and prevents Aβ peptide fibrillation and oligomerisation.

Lu JH, Ardah MT, Durairajan SS, Liu LF, Xie LX, Fong WF, Hasan MY, Huang JD, El-Agnaf OM, Li M.

Chembiochem. 2011 Mar 7;12(4):615-24. doi: 10.1002/cbic.201000604. Epub 2011 Jan 26.

PMID:21271629

Flavones from root of Scutellaria baicalensis Georgi: drugs of the future in neurodegeneration?

Gasiorowski K, Lamer-Zarawska E, Leszek J, Parvathaneni K, Yendluri BB, Błach-Olszewska Z, Aliev G.

CNS Neurol Disord Drug Targets. 2011 Mar;10(2):184-91. Review.

PMID:21222632

Structural characteristics of alpha-synuclein oligomers stabilized by the flavonoid baicalein.

Hong DP, Fink AL, Uversky VN.

J Mol Biol. 2008 Oct 31;383(1):214-23. doi: 10.1016/j.jmb.2008.08.039. Epub 2008 Aug 23.

PMID:18775438

Free PMC Article

The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils.

Zhu M, Rajamani S, Kaylor J, Han S, Zhou F, Fink AL.

J Biol Chem. 2004 Jun 25;279(26):26846-57. Epub 2004 Apr 19.

PMID:15096521

Free Article

 

Curcumin Rescues a PINK1 Knock Down SH-SY5Y Cellular Model of Parkinson’s Disease from Mitochondrial Dysfunction and Cell Death.

van der Merwe C, van Dyk HC, Engelbrecht L, van der Westhuizen FH, Kinnear C, Loos B, Bardien S.

Mol Neurobiol. 2016 Mar 22. [Epub ahead of print]

PMID:27003823

Curcumin improves neurofunctions of 6-OHDA-induced parkinsonian rats.

Song S, Nie Q, Li Z, Du G.

Pathol Res Pract. 2016 Apr;212(4):247-51. doi: 10.1016/j.prp.2015.11.012. Epub 2015 Nov 18.

PMID:26922613

Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt/Nrf2 pathway.

Cui Q, Li X, Zhu H.

Mol Med Rep. 2016 Feb;13(2):1381-8. doi: 10.3892/mmr.2015.4657. Epub 2015 Dec 8.

PMID:26648392

Curcumin inhibits apoptosis by regulating intracellular calcium release, reactive oxygen species and mitochondrial depolarization levels in SH-SY5Y neuronal cells.

Uğuz AC, Öz A, Nazıroğlu M.

J Recept Signal Transduct Res. 2016 Aug;36(4):395-401. doi: 10.3109/10799893.2015.1108337. Epub 2015 Nov 25.

PMID:26608462

Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson’s disease models.

Ganesan P, Ko HM, Kim IS, Choi DK.

Int J Nanomedicine. 2015 Oct 29;10:6757-72. doi: 10.2147/IJN.S93918. eCollection 2015. Review.

PMID:26604750

Free PMC Article

Plant-derived neuroprotective agents in Parkinson’s disease.

Fu W, Zhuang W, Zhou S, Wang X.

Am J Transl Res. 2015 Jul 15;7(7):1189-202. eCollection 2015. Review.

PMID:26328004

Free PMC Article

Curcumin Treatment Improves Motor Behavior in α-Synuclein Transgenic Mice.

Spinelli KJ, Osterberg VR, Meshul CK, Soumyanath A, Unni VK.

PLoS One. 2015 Jun 2;10(6):e0128510. doi: 10.1371/journal.pone.0128510. eCollection 2015.

PMID:26035833

Free PMC Article

Relevance of the anti-inflammatory properties of curcumin in neurodegenerative diseases and depression.

Tizabi Y, Hurley LL, Qualls Z, Akinfiresoye L.

Molecules. 2014 Dec 12;19(12):20864-79. doi: 10.3390/molecules191220864. Review.

PMID:25514226

Free Article

Curcumin’s neuroprotective efficacy in Drosophila model of idiopathic Parkinson’s disease is phase specific: implication of its therapeutic effectiveness.

Phom L, Achumi B, Alone DP, Muralidhara, Yenisetti SC.

Rejuvenation Res. 2014 Dec;17(6):481-9. doi: 10.1089/rej.2014.1591.

PMID:25238331

Free PMC Article

The use of nanopore analysis for discovering drugs which bind to α-synuclein for treatment of Parkinson’s disease.

Tavassoly O, Kakish J, Nokhrin S, Dmitriev O, Lee JS.

Eur J Med Chem. 2014 Dec 17;88:42-54. doi: 10.1016/j.ejmech.2014.07.090. Epub 2014 Jul 25.

PMID:25081642

Neuroprotective effect of curcumin on hippocampal injury in 6-OHDA-induced Parkinson’s disease rat.

Yang J, Song S, Li J, Liang T.

Pathol Res Pract. 2014 Jun;210(6):357-62. doi: 10.1016/j.prp.2014.02.005. Epub 2014 Feb 23.

PMID:24642369

Curcumin protects axons from degeneration in the setting of local neuroinflammation.

Tegenge MA, Rajbhandari L, Shrestha S, Mithal A, Hosmane S, Venkatesan A.

Exp Neurol. 2014 Mar;253:102-10. doi: 10.1016/j.expneurol.2013.12.016. Epub 2013 Dec 29.

PMID:24382451

Protective effects of curcumin against rotenone and salsolinol-induced toxicity: implications for Parkinson’s disease.

Qualls Z, Brown D, Ramlochansingh C, Hurley LL, Tizabi Y.

Neurotox Res. 2014 Jan;25(1):81-9.

PMID:24122264

Free PMC Article

The multiple pharmaceutical potential of curcumin in Parkinson’s disease.

Ji HF, Shen L.

CNS Neurol Disord Drug Targets. 2014 Mar;13(2):369-73. Review.

PMID:23844695

Curcumin modulates α-synuclein aggregation and toxicity.

Singh PK, Kotia V, Ghosh D, Mohite GM, Kumar A, Maji SK.

ACS Chem Neurosci. 2013 Mar 20;4(3):393-407. doi: 10.1021/cn3001203. Epub 2012 Dec 17.

PMID:23509976

Free PMC Article

Curcumin ameliorates the neurodegenerative pathology in A53T α-synuclein cell model of Parkinson’s disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy.

Jiang TF, Zhang YJ, Zhou HY, Wang HM, Tian LP, Liu J, Ding JQ, Chen SD.

J Neuroimmune Pharmacol. 2013 Mar;8(1):356-69. doi: 10.1007/s11481-012-9431-7. Epub 2013 Jan 17.

PMID:23325107

Curcumin inhibition of JNKs prevents dopaminergic neuronal loss in a mouse model of Parkinson’s disease through suppressing mitochondria dysfunction.

Pan J, Li H, Ma JF, Tan YY, Xiao Q, Ding JQ, Chen SD.

Transl Neurodegener. 2012 Aug 20;1(1):16. doi: 10.1186/2047-9158-1-16.

PMID:23210631

Free PMC Article

Neurodegenerative Shielding by Curcumin and Its Derivatives on Brain Lesions Induced by 6-OHDA Model of Parkinson’s Disease in Albino Wistar Rats.

Agrawal SS, Gullaiya S, Dubey V, Singh V, Kumar A, Nagar A, Tiwari P.

Cardiovasc Psychiatry Neurol. 2012;2012:942981. doi: 10.1155/2012/942981. Epub 2012 Aug

Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson’s disease.

Du XX, Xu HM, Jiang H, Song N, Wang J, Xie JX.

Neurosci Bull. 2012 Jun;28(3):253-8. doi: 10.1007/s12264-012-1238-2.

PMID:22622825

Neuroprotective effect of curcuminoids against inflammation-mediated dopaminergic neurodegeneration in the MPTP model of Parkinson’s disease.

Ojha RP, Rastogi M, Devi BP, Agrawal A, Dubey GP.

J Neuroimmune Pharmacol. 2012 Sep;7(3):609-18. doi: 10.1007/s11481-012-9363-2. Epub 2012 Apr 21.

PMID:22527634

Curcumin has neuroprotection effect on homocysteine rat model of Parkinson.

Mansouri Z, Sabetkasaei M, Moradi F, Masoudnia F, Ataie A.

J Mol Neurosci. 2012 Jun;47(2):234-42. doi: 10.1007/s12031-012-9727-3. Epub 2012 Mar 15.

PMID:
22418789
 

Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism.

Liu Z, Yu Y, Li X, Ross CA, Smith WW.

Pharmacol Res. 2011 May;63(5):439-44. doi: 10.1016/j.phrs.2011.01.004. Epub 2011 Jan 12.

PMID:21237271
 

Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson’s disease cell model.

Wang MS, Boddapati S, Emadi S, Sierks MR.

BMC Neurosci. 2010 Apr 30;11:57. doi: 10.1186/1471-2202-11-57.

PMID:20433710

Free PMC Article

Prebiotic Aztec Warrior Coffee!

?????????????????????????????????????????????????????????????????????????????????

Ok, so I still drink coffee, and from the statistics I’ve read, most of you readers probably drink coffee too! I decided to try to make the coffee as healthy as possible, stacking some other health benefits along with reduction of Parkinson’s probability/severity and making the world seem like a happier place. Coffee has also been found to inhibit some types of cancer. Cocoa also has cancer-preventive properties. Cayenne pepper reduces the effects of high cholesterol, helping prevent oxidative stress to heart cells. I’ve read that the Aztecs used coffee, and cocoa and of course cayenne pepper-so why not combine the three? I know I’m not the first to do this, but it certainly does have a particular taste and kick to it! Especially (espressoly?) when made with espresso.

Recently I have been reading quite a bit about Yacon syrup and its health benefits. It turns out that yacon, which is a South American root vegetable, is processed into a molasses-like syrup that is a natural sweetener. If that wasn’t good enough, most of the carbohydrates in the syrup are not digestible, so it is a low-calorie sweetener that isn’t poisonous like Splenda. Yacon is also a prebiotic, with fiber that some of our gut bacteria just love. The species that thrive on it include Bifido and Akkermansia. Why, you ask, is that significant? Bifido is a “colonizer” species that helps to heal gut wall damage, and Akkermansia makes us burn up fat faster-increasing lean mass and lowering BMI. Akkermansia is also helpful in non-alcoholic fatty liver disease, diabetes and immune system regulation.

Since Yacon is also from the same continent (and possibly region) as the Aztecs were, I reasoned that it should be good in coffee! Now, to a double shot of espresso or a mug of normal coffee, I add a teaspoon of cocoa powder and a tablespoon of yacon syrup, and a couple of sprinkles of cayenne pepper. On occasion, I’ve also added half a teaspoon of powdered inulin (another beneficial prebiotic; this one is from Jerusalem Artichoke). The inulin seems to disappear and not add any particular flavor, but the yacon gives the coffee a slight sweetness and the molasses-like flavor complements the cocoa/coffee/cayenne trinity quite nicely! Some who have tried it say that it’s too strong a taste, while many have adopted it as a coffee drink. Our local coffee shop, the Jitterbug, will make an Aztec espresso if asked, though I have yet to introduce them to yacon as a sweetener.

So there you have it-a new coffee drink has been invented and it has some powerful health benefits!

References:

http://www.ncbi.nlm.nih.gov/pubmed/24525422

http://www.ncbi.nlm.nih.gov/pubmed/25535729

http://www.ncbi.nlm.nih.gov/pubmed/25500898

http://www.ncbi.nlm.nih.gov/pubmed/25027235

http://pamw.pl/sites/default/files/PAMW%202014_12_Albini.pdf

http://www.ncbi.nlm.nih.gov/pubmed/25575980

http://www.ncbi.nlm.nih.gov/pubmed/25545102

http://www.ncbi.nlm.nih.gov/pubmed/25372730

http://www.ncbi.nlm.nih.gov/pubmed/25118238

http://www.ncbi.nlm.nih.gov/pubmed/24966608

http://www.ncbi.nlm.nih.gov/pubmed/24857830

http://www.ncbi.nlm.nih.gov/pubmed/24833634